Q4KUS2
Gene name |
Unc13a |
Protein name |
Protein unc-13 homolog A |
Names |
Munc13-1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:382018 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
1002-1521 (MUN domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Target domain |
1002-1521 (MUN domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Target domain |
1002-1521 (MUN domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Accessory elements
No accessory elements
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Palfreyman MT et al. (2017) "Unc13 Aligns SNAREs and Superprimes Synaptic Vesicles", Neuron, 95, 473-475
- Michelassi F et al. (2017) "A C1-C2 Module in Munc13 Inhibits Calcium-Dependent Neurotransmitter Release", Neuron, 95, 577-590.e5
69 variants for Q4KUS2
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3388990900 | 37 | A>V | No | EVA | |
rs3388942551 | 100 | D>Y | No | EVA | |
rs3399224125 | 160 | Q>P | No | EVA | |
rs3388990881 | 174 | C>Y | No | EVA | |
rs3399238502 | 209 | P>S | No | EVA | |
rs3399234377 | 210 | P>L | No | EVA | |
rs3388966663 | 217 | Q>H | No | EVA | |
rs3388991191 | 342 | E>G | No | EVA | |
rs3388988665 | 342 | E>K | No | EVA | |
rs3388977658 | 346 | E>K | No | EVA | |
rs3399238518 | 381 | F>V | No | EVA | |
rs3388991121 | 386 | F>I | No | EVA | |
rs3388988476 | 393 | K>* | No | EVA | |
rs3399066908 | 418 | E>* | No | EVA | |
rs3388966614 | 438 | F>V | No | EVA | |
rs3398787358 | 447 | Q>LDLLGRG* | No | EVA | |
rs3388987343 | 447 | Q>R | No | EVA | |
rs3388984322 | 465 | N>Y | No | EVA | |
rs3388995127 | 473 | E>* | No | EVA | |
rs3388960252 | 475 | R>E* | No | EVA | |
rs3388972092 | 477 | E>* | No | EVA | |
rs3388987350 | 477 | E>D | No | EVA | |
rs108187400 | 479 | D>E | No | EVA | |
rs3388942530 | 497 | I>N | No | EVA | |
rs3412959442 | 525 | A>S | No | EVA | |
rs3388995144 | 547 | K>M | No | EVA | |
rs3388977671 | 551 | Q>* | No | EVA | |
rs3388966667 | 719 | K>T | No | EVA | |
rs3388988672 | 741 | H>N | No | EVA | |
rs3388984310 | 757 | D>E | No | EVA | |
rs3388960286 | 759 | K>N | No | EVA | |
rs3388972130 | 777 | T>I | No | EVA | |
rs3388972093 | 796 | K>N | No | EVA | |
rs3388996005 | 803 | V>A | No | EVA | |
rs3399308784 | 806 | A>V | No | EVA | |
rs3388991168 | 852 | D>G | No | EVA | |
rs3388972085 | 861 | V>A | No | EVA | |
rs3388991333 | 880 | V>I | No | EVA | |
rs3399308751 | 888 | T>S | No | EVA | |
rs3388995184 | 890 | F>S | No | EVA | |
rs3388966574 | 912 | N>K | No | EVA | |
rs3388988465 | 920 | T>I | No | EVA | |
rs3388966628 | 927 | S>Y | No | EVA | |
rs3388966600 | 1005 | V>L | No | EVA | |
rs3388942597 | 1015 | S>Y | No | EVA | |
rs3388988399 | 1017 | Y>* | No | EVA | |
rs3388995155 | 1096 | M>I | No | EVA | |
rs3399308763 | 1128 | K>N | No | EVA | |
rs3399308754 | 1128 | K>T | No | EVA | |
rs3399446594 | 1129 | V>L | No | EVA | |
rs3388942577 | 1159 | I>V | No | EVA | |
rs3388942557 | 1205 | L>F | No | EVA | |
rs3388988670 | 1242 | A>E | No | EVA | |
rs3388983744 | 1265 | M>L | No | EVA | |
rs3388984270 | 1277 | K>E | No | EVA | |
rs3388991331 | 1386 | E>Q | No | EVA | |
rs3388983689 | 1395 | M>L | No | EVA | |
rs3388966601 | 1425 | R>K | No | EVA | |
rs3388991199 | 1425 | R>S | No | EVA | |
rs3388988452 | 1436 | Q>L | No | EVA | |
rs3388995143 | 1444 | E>K | No | EVA | |
rs3388993935 | 1462 | S>I | No | EVA | |
rs3388983571 | 1470 | V>F | No | EVA | |
rs3388987352 | 1485 | G>V | No | EVA | |
rs3388984244 | 1516 | L>M | No | EVA | |
rs3388983684 | 1567 | K>N | No | EVA | |
rs3388991374 | 1621 | P>T | No | EVA | |
rs3388991361 | 1637 | R>C | No | EVA | |
rs3388990905 | 1695 | K>M | No | EVA |
No associated diseases with Q4KUS2
8 regional properties for Q4KUS2
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | C2 domain | 1 - 98 | IPR000008-1 |
domain | C2 domain | 668 - 794 | IPR000008-2 |
domain | C2 domain | 1535 - 1664 | IPR000008-3 |
domain | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain | 562 - 612 | IPR002219 |
domain | MUN domain | 1002 - 1521 | IPR010439 |
domain | Munc13 homology 1 | 1102 - 1245 | IPR014770 |
domain | Mammalian uncoordinated homology 13, domain 2 | 1354 - 1521 | IPR014772 |
domain | Protein Unc-13, C2B domain | 685 - 811 | IPR037302 |
Functions
17 GO annotations of cellular component
Name | Definition |
---|---|
axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
calyx of Held | The terminal specialization of a calyciferous axon which forms large synapses in the mammalian auditory central nervous system. |
excitatory synapse | A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. |
glutamatergic synapse | A synapse that uses glutamate as a neurotransmitter. |
Golgi-associated vesicle | Any vesicle associated with the Golgi complex and involved in mediating transport within the Golgi or between the Golgi and other parts of the cell. |
neuromuscular junction | The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential. |
neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
presynapse | The part of a synapse that is part of the presynaptic cell. |
presynaptic active zone | A specialized region of the plasma membrane and cell cortex of a presynaptic neuron; encompasses a region of the plasma membrane where synaptic vesicles dock and fuse, and a specialized cortical cytoskeletal matrix. |
presynaptic active zone cytoplasmic component | A specialized region below the presynaptic membrane, characterized by electron-dense material, a specialized cytoskeletal matrix and accumulated (associated) synaptic vesicles. |
presynaptic membrane | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
synaptic membrane | A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell. |
synaptic vesicle membrane | The lipid bilayer surrounding a synaptic vesicle. |
terminal bouton | Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. |
11 GO annotations of molecular function
Name | Definition |
---|---|
calcium ion binding | Binding to a calcium ion (Ca2+). |
calmodulin binding | Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. |
diacylglycerol binding | Binding to a diacylglycerol, a diester of glycerol and two fatty acids. |
identical protein binding | Binding to an identical protein or proteins. |
phospholipid binding | Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester. |
protein domain specific binding | Binding to a specific domain of a protein. |
protein-containing complex binding | Binding to a macromolecular complex. |
SNARE binding | Binding to a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein. |
spectrin binding | Binding to spectrin, a protein that is the major constituent of the erythrocyte cytoskeletal network. It associates with band 4.1 (see band protein) and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane. It is composed of nonhomologous chains, alpha and beta, which aggregate side-to-side in an antiparallel fashion to form dimers, tetramers, and higher polymers. |
syntaxin binding | Binding to a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse. |
syntaxin-1 binding | Binding to a syntaxin-1 SNAP receptor. |
20 GO annotations of biological process
Name | Definition |
---|---|
amyloid-beta metabolic process | The chemical reactions and pathways involving amyloid-beta, a glycoprotein associated with Alzheimer's disease, and its precursor, amyloid precursor protein (APP). |
cell differentiation | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
dense core granule priming | A process that converts unprimed dense core granules (DCVs) to a pool of primed vesicles that are capable of fusing with the plasma membrane (fusion-competent) and thereby releasing their contents. Priming typically occurs after docking. |
innervation | The process in which a nerve invades a tissue and makes functional synaptic connection within the tissue. |
long-term synaptic potentiation | A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse. |
neuromuscular junction development | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction. |
neuronal dense core vesicle exocytosis | The secretion of molecules (e.g. neuropeptides, insulin-related peptides or neuromodulators such as serotonin and dopamine) contained within a neuronal dense core vesicle by fusion of the granule with the plasma membrane of a neuron in response to increased cytosolic calcium levels. |
neurotransmitter secretion | The regulated release of neurotransmitter from the presynapse into the synaptic cleft via calcium-regulated exocytosis during synaptic transmission. |
positive regulation of glutamate receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of glutamate receptor signaling pathway. |
positive regulation of neurotransmitter secretion | Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter. |
positive regulation of synaptic plasticity | A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. |
presynaptic dense core vesicle exocytosis | The secretion of molecules (e.g. neuropeptides and neuromodulators such as serotonin and dopamine) contained within a membrane-bounced dense in response to increased presynaptic cytosolic calcium levels. |
regulation of amyloid precursor protein catabolic process | Any process that modulates the frequency, rate or extent of amyloid precursor protein catabolic process. |
regulation of short-term neuronal synaptic plasticity | A process that modulates short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity. |
regulation of synaptic vesicle priming | Any process that modulates the frequency, rate or extent of synaptic vesicle priming. Synaptic vesicle priming is the formation of SNARE-containing complexes, bringing synaptic vesicle membrane and plasma membranes into close proximity and thereby facilitating membrane fusion. |
synaptic transmission, glutamatergic | The vesicular release of glutamate from a presynapse, across a chemical synapse, the subsequent activation of glutamate receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. |
synaptic vesicle docking | The initial (indirect) attachment of a synaptic vesicle membrane to the presynaptic active zone membrane, mediated by proteins protruding from the membrane and proteins of the presynaptic active zone cytoplasmic component. Synaptic vesicle tethering is the first step in this process. |
synaptic vesicle exocytosis | Fusion of intracellular membrane-bounded vesicles with the pre-synaptic membrane of the neuronal cell resulting in release of neurotransmitter into the synaptic cleft. |
synaptic vesicle maturation | Steps required to form an initiated synaptic vesicle into a fully formed and transmissible synaptic vesicle. |
synaptic vesicle priming | A process that converts synaptic vesicles to a state of competence for calcium triggered fusion with the active zone membrane by bringing the two membranes into very close proximity. Priming typically (but not always) occurs after docking (Jahn and Fasshauer, 2012). Primed vesicles are also capable of spontaneously fusing with the active zone membrane. |
9 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
O14795 | UNC13B | Protein unc-13 homolog B | Homo sapiens (Human) | SS |
Q8NB66 | UNC13C | Protein unc-13 homolog C | Homo sapiens (Human) | SS |
Q9UPW8 | UNC13A | Protein unc-13 homolog A | Homo sapiens (Human) | SS |
Q8K0T7 | Unc13c | Protein unc-13 homolog C | Mus musculus (Mouse) | SS |
Q9Z1N9 | Unc13b | Protein unc-13 homolog B | Mus musculus (Mouse) | SS |
Q62770 | Unc13c | Protein unc-13 homolog C | Rattus norvegicus (Rat) | SS |
Q62769 | Unc13b | Protein unc-13 homolog B | Rattus norvegicus (Rat) | SS |
Q62768 | Unc13a | Protein unc-13 homolog A | Rattus norvegicus (Rat) | SS |
P27715 | unc-13 | Phorbol ester/diacylglycerol-binding protein unc-13 | Caenorhabditis elegans | EV |
10 | 20 | 30 | 40 | 50 | 60 |
MSLLCVGVKK | AKFDGAQEKF | NTYVTLKVQN | VKSTTIAVRG | SQPSWEQDFM | FEINRLDLGL |
70 | 80 | 90 | 100 | 110 | 120 |
TVEVWNKGLI | WDTMVGTVWI | PLRTIRQSNE | EGPGEWLTLD | SQAIMADSEI | CGTKDPTFHR |
130 | 140 | 150 | 160 | 170 | 180 |
ILLDAHFELP | LDIPEEEARY | WAKKLEQLNA | MRDQDEYSFQ | DQQDKPLPVP | SSQCCNWNYF |
190 | 200 | 210 | 220 | 230 | 240 |
GWGEQNDDPD | SAVDDRDSDY | RSETSNSIPP | PYYTTSQPNA | SVHQYSVRPP | PLGSRESYSD |
250 | 260 | 270 | 280 | 290 | 300 |
SMHSYEEFSE | PRALSPTGSS | RYASSGELSQ | GSSQLSEDFD | PDEHSLQGSE | LDDERDRDSY |
310 | 320 | 330 | 340 | 350 | 360 |
HSCHSSVSYH | KDSPRWDQDD | EDLEDLEDLE | DEELPEEEEE | LEEEGEEELE | EEDLEEEEEV |
370 | 380 | 390 | 400 | 410 | 420 |
PDDLASYTQQ | EDTTVAEPKE | FKRISFPTAA | PQKDDKVSAV | PTEAPEVAKG | IPKAATPEEK |
430 | 440 | 450 | 460 | 470 | 480 |
AAAERAQEAE | PPKSEESFRS | REEEEGQEGQ | DAMSRAKANW | LRAFNKVRMQ | LQEARGEGDM |
490 | 500 | 510 | 520 | 530 | 540 |
SKSLWFKGGP | GGGLIIIDSM | PDIRKRKPIP | LVSDLAMSLV | QSRKAGITSA | LASSTLNNEE |
550 | 560 | 570 | 580 | 590 | 600 |
LKNHVYKKTL | QALIYPISCT | TPHNFEVWTA | TTPTYCYECE | GLLWGIARQG | MRCTECGVKC |
610 | 620 | 630 | 640 | 650 | 660 |
HEKCQDLLNA | DCLQRAAEKS | SKHGAEDRTQ | NIIMVLKDRM | KIRERNKPEI | FELIQEIFAV |
670 | 680 | 690 | 700 | 710 | 720 |
TKSAHTQQMK | AVKQSVLDGT | SKWSAKISIT | VVCAQGLQAK | DKTGSSDPYV | TVQVGKTKKR |
730 | 740 | 750 | 760 | 770 | 780 |
TKTIYGNLNP | VWEENFHFEC | HNSSDRIKVR | VWDEDDDIKS | RVKQRFKRES | DDFLGQTIIE |
790 | 800 | 810 | 820 | 830 | 840 |
VRTLSGEMDV | WYNLDKRTDK | SAVSGAIRLH | ISVEIKGEEK | VAPYHVQYTC | LHENLFHFVT |
850 | 860 | 870 | 880 | 890 | 900 |
DVQNNGVVKI | PDAKGDDAWK | VYYDETAQEI | VDEFAMRYGV | ESIYQAMTHF | ACLSSKYMCP |
910 | 920 | 930 | 940 | 950 | 960 |
GVPAVMSTLL | ANINAYYAHT | TASTNVSASD | RFAASNFGKE | RFVKLLDQLH | NSLRIDLSMY |
970 | 980 | 990 | 1000 | 1010 | 1020 |
RNNFPASSPE | RLQDLKSTVD | LLTSITFFRM | KVQELQSPPR | ASQVVKDCVK | ACLNSTYEYI |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
FNNCHELYGR | EYQTDPAKKG | EVPPEEQGPS | IKNLDFWSKL | ITLIVSIIEE | DKNSYTPCLN |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
QFPQELNVGK | ISAEVMWSLF | AQDMKYAMEE | HDKHRLCKSA | DYMNLHFKVK | WLYNEYVAEL |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
PTFKDRVPEY | PAWFEPFVIQ | WLDENEEVSR | DFLHGALERD | KKDGFQQTSE | HALFSCSVVD |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
VFSQLNQSFE | IIKKLECPDP | QIVGHYMRRF | AKTISNVLLQ | YADIVSKDFA | SYCSKEKEKV |
1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
PCILMNNTQQ | LRVQLEKMFE | AMGGKELDAE | ASGTLKELQV | KLNNVLDELS | HVFATSFQPH |
1330 | 1340 | 1350 | 1360 | 1370 | 1380 |
IEECVRQMGD | ILSQVKGTGN | VPASACSSVA | QDADNVLQPI | MDLLDSNLTL | FAKICEKTVL |
1390 | 1400 | 1410 | 1420 | 1430 | 1440 |
KRVLKELWKL | VMNTMEKTIV | LPPLTDQTMI | GTLLRKHGKG | LEKGRVKLPS | HSDGTQMIFN |
1450 | 1460 | 1470 | 1480 | 1490 | 1500 |
AAKELGQLSK | LKDHMVREEA | KSLTPKQCAV | VELALDTIKQ | YFHAGGVGLK | KTFLEKSPDL |
1510 | 1520 | 1530 | 1540 | 1550 | 1560 |
QSLRYALSLY | TQATDLLIKT | FVQTQSAQGS | GVEDPVGEVS | VHVELFTHPG | TGEQKVTVKV |
1570 | 1580 | 1590 | 1600 | 1610 | 1620 |
VAANDLKWQT | SGIFRPFIEV | NIVGPQLSDK | KRKFATKSKN | NSWAPKYNES | FQFSLSADAG |
1630 | 1640 | 1650 | 1660 | 1670 | 1680 |
PECYELQVCV | KDYCFAREDR | TVGLAVLQLR | ELAQRGSAAC | WLPLGRRIHM | DDTGLTVLRI |
1690 | 1700 | 1710 | |||
LSQRSNDEVA | KEFVKLKSDT | RSAEEGGAAP | AP |